What is the price target for VTGN stock?
10 analysts have analysed VTGN and the average price target is 3.8 USD. This implies a price increase of 566.58% is expected in the next year compared to the current price of 0.57.
VISTAGEN THERAPEUTICS INC (VTGN) Forecast, Price Target & Analyst Ratings
NASDAQ:VTGN • US92840H4002
Current stock price
0.57 USD
-0.03 (-5.38%)
At close:
0.5822 USD
+0.01 (+2.14%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VISTAGEN THERAPEUTICS INC (VTGN).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Jun 15, 2026
- Period
- Q4 / 2026
- EPS Estimate
- -$0.34
- Revenue Estimate
- 273.023K
Price Target Details & History
Consensus Price Target and Range
Mean target
$3.80
Upside
+ 566.58%
From current price of $0.57 to mean target of $3.80, Based on 10 analyst forecasts
Low
$0.91
Median
$1.02
High
$12.60
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
10 Wall Street analysts provided a forecast for the next 12 months for VTGN. The average price target is 3.8 USD. This implies a price increase of 566.58% is expected in the next year compared to the current price of 0.57.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
50.00%
VTGN was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about VTGN.
In the previous month the buy percentage consensus was at a similar level.
VTGN was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-12-17 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-12-17 | Maxim Group | Downgrade | Buy -> Hold |
| 2025-12-17 | Jefferies | Downgrade | Buy -> Hold |
| 2023-12-07 | Jefferies | Upgrade | Hold -> Buy |
| 2023-11-14 | Stifel | Initiate | Buy |
| 2023-09-05 | Maxim Group | Maintains | Buy -> Buy |
| 2023-08-07 | Maxim Group | Upgrade | Hold -> Buy |
| 2022-07-26 | Maxim Group | Downgrade | Buy -> Hold |
| 2022-07-22 | William Blair | Downgrade | Outperform -> Market Perform |
| 2021-05-20 | Baird | Initiate | Outperform |
| 2021-02-18 | Jefferies | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Jun 15, 2026
- Period
- Q4 / 2026
- EPS Estimate
- -$0.34
- Revenue Estimate
- 273.023K
- Revenue Q2Q
- 1,720.16%
- EPS Q2Q
- 20.51%
- Number of Analysts
- 7
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-16.18%
EPS (1 Month)
0.00%
EPS (3 Months)
11.40%
Next Earnings Summary
VTGN is expected to report earnings on 6/15/2026. The consensus EPS estimate for the next earnings is -0.34 USD and the consensus revenue estimate is 273.02K USD.
The next earnings revenue estimate has been revised downward by 16.18% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -230K -120.72% | 1.064M 562.61% | 486K -54.32% | 1.091M 124.49% | 4.953M 353.99% | 131.9M 2,563.03% | 142.99M 8.41% | 308.97M 116.08% | 880.53M 184.99% | 1.251B 42.07% | 1.286B 2.80% | |
| EBITDA YoY % growth | -59.14M -24.17% | -32.894M 44.38% | -55.823M -69.71% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -59.27M -24.05% | -33.021M 44.29% | -55.973M -69.51% | -71.494M -27.73% | -68.961M 3.54% | -68.362M 0.87% | 9.252M 113.53% | 115.68M 1,150.32% | 529.7M 357.90% | 800.76M 51.17% | 820.71M 2.49% | |
| Operating Margin | 25,769.57% | -3,103.48% | -11,517.08% | -6,553.03% | -1,392.30% | -51.83% | 6.47% | 37.44% | 60.16% | 64.01% | 63.82% | |
| EPS YoY % growth | -8.65 -15.33% | N/A 81.16% | -1.66 -2.00% | -1.82 -9.24% | -1.12 38.39% | -1.56 -39.51% | 0.26 116.34% | 2.01 690.00% | 8.48 320.76% | 12.36 45.85% | 12.34 -0.17% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.34 20.51% | -0.26 45.74% | -0.27 49.63% | -0.29 36.53% | -0.24 30.69% |
| Revenue Q2Q % growth | 273.023K 1,720.16% | 309.06K 26.66% | 309.06K 19.79% | 309.06K 2.00% | 4.469M 1,536.86% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.983M 16.87% | -14.635M 7.39% | -16.675M 16.84% | -19.225M 1.64% | -21.265M -41.93% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
1.99%
EPS Next 5 Year
26.29%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
466.75%
Revenue Next 5 Year
235.72%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
VISTAGEN THERAPEUTICS INC / VTGN Forecast FAQ
Can you provide the upcoming earnings date for VISTAGEN THERAPEUTICS INC?
VISTAGEN THERAPEUTICS INC (VTGN) will report earnings on 2026-06-15, after the market close.
What are the consensus estimates for VTGN stock next earnings?
The consensus EPS estimate for the next earnings of VISTAGEN THERAPEUTICS INC (VTGN) is -0.34 USD and the consensus revenue estimate is 273.02K USD.
What is the expected long term growth rate for VISTAGEN THERAPEUTICS INC (VTGN)?
The expected long term growth rate for VISTAGEN THERAPEUTICS INC (VTGN) is 466.75%.